抗体
试剂盒
多肽
探针
蛋白
组织芯片
产品中心
Product Center
Research Grade Motavizumab
All
TD-VK421036_1.jpg
TD-VK421036_2.jpg
TD-VK421036_3.jpg
- Catalog： TD-VK421036
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： MEDI-524,NUMAX,NISTmAb,CR9503,CAS:677010-34-3
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Motavizumab
| Catalog No. | TD-VK421036 |
|---|---|
| Description | Motavizumab (MEDI-524, NUMAX, NISTmAb) is a second generation monoclonal antibody (mAb) derived from palivizumab (Synagis) using affinity maturation techniques. Motavizumab is currently undergoing US Food and Drug Administration review as a treatment for respiratory syncytial virus (RSV) prophylaxis. It has been evaluated in large-scale clinical studies, and has demonstrated efficacy in reducing the disease burden of RSV in high-risk infant populations. Motavizumab (MEDI-524, NUMAX, NISTmAb) has higher affinity and a longer half-life, was effective in reducing RSV hospitalization in high-risk full-term infants in the US, but was not licensed due to safety concerns (allergic reactions). |
| Species reactivity | HRSV-A |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1, kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P03420 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | MEDI-524,NUMAX,NISTmAb,CR9503,CAS:677010-34-3 |
| Background | Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Motavizumab. |
|
|
Detects F/Fusion glycoprotein F0 in indirect ELISAs. |
|
|
SDS-PAGE for Research Grade Motavizumab. |